Urine metabolites are associated with glomerular lesions in type 2 diabetes
- PMID: 30830355
- PMCID: PMC6461445
- DOI: 10.1007/s11306-018-1380-6
Urine metabolites are associated with glomerular lesions in type 2 diabetes
Abstract
Introduction: Little is known about the association of urine metabolites with structural lesions in persons with diabetes.
Objectives: We examined the relationship between 12 urine metabolites and kidney structure in American Indians with type 2 diabetes.
Methods: Data were from a 6-year clinical trial that assessed renoprotective efficacy of losartan, and included a kidney biopsy at the end of the treatment period. Metabolites were measured in urine samples collected within a median of 6.5 months before the research biopsy. Associations of the creatinine-adjusted urine metabolites with kidney structural variables were examined by Pearson's correlations and multivariable linear regression after adjustment for age, sex, diabetes duration, hemoglobin A1c, mean arterial pressure, glomerular filtration rate (iothalamate), and losartan treatment.
Results: Participants (n = 62, mean age 45 ± 10 years) had mean ± standard deviation glomerular filtration rate of 137 ± 50 ml/min and median (interquartile range) urine albumin:creatinine ratio of 34 (14-85) mg/g near the time of the biopsy. Urine aconitic and glycolic acids correlated positively with glomerular filtration surface density (partial r = 0.29, P = 0.030 and r = 0.50, P < 0.001) and total filtration surface per glomerulus (partial r = 0.32, P = 0.019 and r = 0.43, P = 0.001). 2-ethyl 3-OH propionate correlated positively with the percentage of fenestrated endothelium (partial r = 0.32, P = 0.019). Citric acid correlated negatively with mesangial fractional volume (partial r=-0.36, P = 0.007), and homovanillic acid correlated negatively with podocyte foot process width (partial r=-0.31, P = 0.022).
Conclusions: Alterations of urine metabolites may associate with early glomerular lesions in diabetic kidney disease.
Keywords: Biomarkers; Kidney structure; Metabolites; Type 2 Diabetes.
Conflict of interest statement
Compliance with ethical standards
Conflict of interest Pierre-Jean Saulnier, Manjula Darshi, Kevin M. Wheelock, Helen C. Looker, Gudeta D. Fufaa, William C. Knowler, E. Jennifer Weil, Stephanie K. Tanamas, Kevin V. Lemley, Rintaro Saito, Loki Natarajan, Robert G. Nelson, and Kumar Sharma declare that they have no conflict of interest.
Figures

Similar articles
-
Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.Clin J Am Soc Nephrol. 2016 Feb 5;11(2):254-61. doi: 10.2215/CJN.05760515. Epub 2016 Jan 20. Clin J Am Soc Nephrol. 2016. PMID: 26792530 Free PMC article.
-
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.J Am Soc Nephrol. 2019 Jun;30(6):1049-1059. doi: 10.1681/ASN.2018111166. J Am Soc Nephrol. 2019. PMID: 31152118 Free PMC article. Clinical Trial.
-
Advanced Glycation End Products Predict Loss of Renal Function and Correlate With Lesions of Diabetic Kidney Disease in American Indians With Type 2 Diabetes.Diabetes. 2016 Dec;65(12):3744-3753. doi: 10.2337/db16-0310. Epub 2016 Sep 8. Diabetes. 2016. PMID: 27609106 Free PMC article. Clinical Trial.
-
Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Kidney Int. 2016 Jan;89(1):226-34. doi: 10.1038/ki.2015.278. Epub 2016 Jan 4. Kidney Int. 2016. PMID: 26398493 Free PMC article.
-
Urine inositol pentakisphosphate 2-kinase and changes in kidney structure in early diabetic kidney disease in type 1 diabetes.Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1484-F1492. doi: 10.1152/ajprenal.00183.2018. Epub 2018 Aug 22. Am J Physiol Renal Physiol. 2018. PMID: 30132343 Free PMC article.
Cited by
-
Fecal Microbiome and Urine Metabolome Profiling of Type 2 Diabetes.J Microbiol Biotechnol. 2025 Mar 11;35:e2411071. doi: 10.4014/jmb.2411.11071. J Microbiol Biotechnol. 2025. PMID: 40147938 Free PMC article.
-
Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration.Sci Rep. 2021 Apr 21;11(1):8592. doi: 10.1038/s41598-021-87585-1. Sci Rep. 2021. PMID: 33883567 Free PMC article.
-
Plasma levels of carboxylic acids are markers of early kidney dysfunction in young people with type 1 diabetes.Pediatr Nephrol. 2023 Jan;38(1):193-202. doi: 10.1007/s00467-022-05531-3. Epub 2022 May 4. Pediatr Nephrol. 2023. PMID: 35507146 Free PMC article. Clinical Trial.
-
The Potential Use of Targeted Proteomics and Metabolomics for the Identification and Monitoring of Diabetic Kidney Disease.J Pers Med. 2024 Oct 11;14(10):1054. doi: 10.3390/jpm14101054. J Pers Med. 2024. PMID: 39452561 Free PMC article. Review.
-
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease.Front Endocrinol (Lausanne). 2022 Jan 26;12:757228. doi: 10.3389/fendo.2021.757228. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35222262 Free PMC article.
References
-
- Beger RD, Holland RD, Sun J, Schnackenberg LK, Moore PC, Dent CL, et al. (2008). Metabonomics of acute kidney injury in children after cardiac surgery. Pediatric Nephrology, 23, 977–984. - PubMed
-
- Belsley DA, Kuh E, & Welsch RE (1980). Regression Diagnostics: Identifying Influential Observations and Sources of Collinearity Hoboken: John Wiley and Sons.
-
- de Cavanagh EM, Inserra F, & Ferder L (2011). Angiotensin II blockade: A strategy to slow ageing by protecting mitochondria? Cardiovascular Research, 89, 31–40. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical